For those contributors who live with rheumatoid arthritis, there is a relatively new class of medications which are worth considering.

They are genetically-engineered monoclonal antibodies which block the action of a protein called TNF. TNF is a protein which plays a significant role in the inflammatory response which is part of rheumatoid arthritis and some other auto-immune diseases.

There is some information about them here: https://www.rheumatology.org/Practic...ions/Anti-TNF/ .

They are an option which is worth discussing with your clinical care teams.